Roche’s Half-Year Results 2026 Presentation
Roche has published its Half-Year Results for 2026 prior to the opening of the Swiss Stock Exchange on Thursday, 23 July 2026
| Agenda | |
|---|---|
| Overview | Thomas Schinecker, CEO Roche Group |
| Financial Results | Alan Hippe, Chief Financial Officer |
| Pharmaceuticals Division | Teresa Graham, CEO Roche Pharmaceuticals |
| Diagnostics Division | Matt Sause, CEO Roche Diagnostics |
| Q&A | Bruno Eschli, Head of Investor Relations |
Webinar Replay
Please click the video below to watch the replay of the webinar.
Investors